Benchmark Reiterates Speculative Buy on Modular Medical, Maintains $5 Price Target
Portfolio Pulse from Benzinga Newsdesk
Benchmark analyst Bruce Jackson reiterates a Speculative Buy rating on Modular Medical (NASDAQ:MODD) and maintains a $5 price target.

March 21, 2024 | 2:09 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Benchmark analyst Bruce Jackson reiterates a Speculative Buy rating on Modular Medical and maintains a $5 price target.
The reiteration of a Speculative Buy rating and the maintenance of a $5 price target by a Benchmark analyst could positively influence investor sentiment towards MODD, potentially driving its stock price up in the short term.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100